Literature DB >> 31246273

mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis.

Magdalena Paplińska-Goryca1, Krzysztof Goryca2, Paulina Misiukiewicz-Stępień3, Patrycja Nejman-Gryz1, Małgorzata Proboszcz1, Katarzyna Górska1, Marta Maskey-Warzęchowska1, Rafał Krenke1.   

Abstract

BACKGROUND: Sarcoidosis and idiopathic pulmonary fibrosis (IPF) are two most frequent forms of interstitial lung diseases (ILDs). Cellular and biochemical composition of bronchoalveolar lavage fluid (BALf) was shown to reflect the fibrotic changes in the lung. However, the usefulness of BALf cellular profile evaluation in the diagnosis of ILDs is limited. The aim of the study was a multivariate, molecular analysis of BALf cells from IPF and sarcoidosis patients.
METHODS: Transcriptomic measurements were carried out using Affymetrix Human Gene 2.1 ST ArrayStrip in 21 samples: 9 IPF and 12 sarcoidosis. The mRNA expression for the most significantly differentiating genes was evaluated by real-time PCR in 32 samples (11 IPF and 21 sarcoidosis).
RESULTS: The number of genes differentially expressed between IPF and sarcoidosis groups was 4832 (13359 probesets). Cluster analysis indicated that sarcoidosis BALf cells are characterized by increased mRNA expression of genes associated with ribosome biogenesis. Clusters formed by genes with changed mRNA expression in IPF samples were implicated in the processes of cell adhesion and migration, metalloproteinase expression and negative regulation of cell proliferation. The GO analysis indicated that predominant biological processes associated with the differential mRNA gene expression of BALf cells were upregulation of neutrophils in IPF and lymphocytes in sarcoidosis.
CONCLUSIONS: Analysis of BALf from sarcoidosis and IPF showed highly different mRNA profile of cells. The most important biological processes observed at the molecular level in BALf cells were associated with ribosome biogenesis and proteasome apparatus in sarcoidosis and neutrophilic dysfunction in IPF.
© 2019 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  bronchoalveolar lavage fluid; idiopathic pulmonary fibrosis; interstitial lung diseases; mRNA; sarcoidosis

Mesh:

Substances:

Year:  2019        PMID: 31246273     DOI: 10.1111/eci.13153

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  Molecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease.

Authors:  Chad A Newton; Erica L Herzog
Journal:  Clin Chest Med       Date:  2021-06       Impact factor: 4.967

2.  S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Yupeng Li; Yaowu He; Shibin Chen; Qi Wang; Yi Yang; Danting Shen; Jing Ma; Zhe Wen; Shangwei Ning; Hong Chen
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

3.  Complex Involvement of the Extracellular Matrix, Immune Effect, and Lipid Metabolism in the Development of Idiopathic Pulmonary Fibrosis.

Authors:  Weiping Qian; Shu Xia; Xiaoyun Yang; Jiaying Yu; Bingpeng Guo; Zhengfang Lin; Rui Wei; Mengmeng Mao; Ziyi Zhang; Gui Zhao; Junye Bai; Qian Han; Zhongfang Wang; Qun Luo
Journal:  Front Mol Biosci       Date:  2022-01-31

4.  Expression of S100A9 and KL-6 in common interstitial lung diseases.

Authors:  Li Lin; Yabin Zhao; Zhenhua Li; Yun Li; Wei Wang; Jian Kang; Qiuyue Wang
Journal:  Medicine (Baltimore)       Date:  2022-04-29       Impact factor: 1.817

5.  Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis.

Authors:  Yasushi Horimasu; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Takeshi Masuda; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

Review 6.  Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.

Authors:  Elvis Hysa; Carlo Alberto Cutolo; Emanuele Gotelli; Greta Pacini; Carlotta Schenone; Elke O Kreps; Vanessa Smith; Maurizio Cutolo
Journal:  Eur J Clin Invest       Date:  2021-05-05       Impact factor: 4.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.